A Multicenter, Open-label, Long-term, Phase 3 Study to Evaluate the Safety and Efficacy of TVP-1012 at 1 mg in Levodopa Treated Parkinson's Disease Patients
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007411/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate long-term safety of TVP-1012 (1 mg/day) with
levodopa in Japanese participants with Parkinson's disease.
本研究旨在评估TVP-1012（每日1mg）联合左旋多巴在日本帕金森病受试者中的长期安全性。
提供机构：
Vivli
创建时间：
2021-09-22
